ILLUMINA INC

Illumina’s board shifts to equity‑based retainer fees, giving directors shares that align interests and signal confidence in the company’s growth and governance.

Illumina shares hit a 52‑week high at $277.95, fueled by biotech momentum, falling Treasury yields, and strong future growth prospects.